Holen Sie sich die Stockscreener-App
39.14
0.63%
-0.25
Handel nachbörslich:
39.14
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
19,723 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Wellington Management Group LLP - MarketBeat
Hyaluronidase Market Massive Growth Predicted (2024-2031) | - openPR
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 7,000 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals executive sells shares worth $672,815 - Investing.com
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Prospects Need A Boost To Lift Shares - Simply Wall St
World Investment Advisors LLC Takes $1.61 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 5.4%What's Next? - MarketBeat
XTX Topco Ltd Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
The Manufacturers Life Insurance Company Trims Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Decreased by Centiva Capital LP - MarketBeat
Point72 Asset Management L.P. Sells 197,019 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Breaks Above 200-Day Moving AverageBullish for AMPH - Nasdaq
Charles Schwab Investment Management Inc. Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Taika Capital LP Makes New $1.79 Million Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today? - Yahoo Finance
Hotchkis & Wiley Capital Management LLC Acquires Shares of 222,620 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options - Yahoo Finance
BNP Paribas Financial Markets Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Dynamic Technology Lab Private Ltd Sells 11,224 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Glenmede Trust Co. NA Buys 22,439 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Where are the Opportunities in (AMPH) - Stock Traders Daily
Intech Investment Management LLC Purchases 2,331 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Thrivent Financial for Lutherans - Defense World
Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now? - Yahoo Finance
12 Most Profitable Pharmaceutical Stocks Right Now - Insider Monkey
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors - Simply Wall St
Financial Review: UroGen Pharma (NASDAQ:URGN) and Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference - AccessWire
Amphastar Continues To Push Proprietary Portfolio With Focus On Baqsimi - Citeline
Algert Global LLC Purchases New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar initiated with an Equal Weight at Wells Fargo - MSN
Connor Clark & Lunn Investment Management Ltd. Sells 20,448 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Segall Bryant & Hamill LLC Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated at Wells Fargo & Company - Defense World
Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle By Investing.com - Investing.com South Africa
GSA Capital Partners LLP Invests $303,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Wells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight Recommendation - MSN
Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle - Investing.com
Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016. - Marketscreener.com
Victory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Victory Capital Management Inc. Has $10.61 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Injectables Contraceptives Market with Promising Opportunity - openPR
Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat
Amphastar Pharmaceuticals executive sells $336,929 in stock By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com
Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire
Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by US Bancorp DE - Defense World
FDA Approves Amphastar's New Epinephrine Drug, Boosting Market Growth - openPR
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings - MSN
Amphastar Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by New York State Teachers Retirement System - Defense World
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):